IL6 and Insulin resistance: A previous investigation of endometrial morphology and molecular pathways following bariatric surgery-induced weight loss demonstrated reduction in biomarkers of insulin resistance (hemoglobin A1C, HOMA-IR) and inflammation (hsCRP, IL-6) demonstrating potential mechanisms by which weight loss may impact endometrial cancer risk (10).